Performance Analysis of MAX India - by mittar_b
Max India (MAX) a multi business company which was incorporated on 5th Feb, 1982 deals with various business activities of healthcare, life insurance and clinical research. The company also focuses on Healthcare staffing and plastic products. Mr Analjit Singh is the founder and the Current Chairman of the company. The company started its commercial operations on 15th January, 1985 by setting up India’s first plant for manufacturing 6APA drug which was an intermediate for penicillin and this plant was the first manufacturing plant in the country which received approval from the U.S. FDA. In the year 1987 the company set up a second drug plant for manufacturing 7ADCA which was also the first in its kind in the country. In the year 1989 the company got engaged into the business of manufacturing BOPP(Bi-axially oriented polyproplene film) in agreement with Punjab State Industrial Development Corporation which was promoted by the name of Maxxon. The company entered into Telecom Sector in the year 1992 in collaboration with Hutchison Telecommunications Limited, Hong Kong for providing Cellular and Radio Paging Services. Following this the company was divided into four divisions namely Max Phrama, Max, Electronics, Maxxon and Max Telecom. The company entered into a 50:50 joint venture with a Netherland based company titled Gist-Brocades for manufacturing and marketing Penicillin based drugs and other drugs like Ampicillin, Amoxycillin and Cephalexin in 1993 with the name of Max Gb and this integration made the company the largest manufacturers of these drugs not only in India but Asia also.
The Business Divisions of the company are as follows:-
- Max Healthcare
- Max New York Life
- Neeman Medical International
- Max Healthstaff
- Max Speciality Products
The Healthcare division of the company Max Healthcare offers medical services and has specialized centers and hospitals. This division of the company has around 2500 physicians associated with it. In this divsion 60 nurses have already been placed in US and around 650 nurses are in the Queue. The life insurance division of the company (Max New york Life) offers innovative life insurance solutions with over 27,500 agents working with this division. The company has entered into a joint venture with a global giant known as Neeman Medical International in its clinical research division.Max Speciality Products specializes in manufacturing BOPP films, metallized BOPP films, thermal plastic films and leather transfering finishing foils. The company’s state of the art manufacturing plant at Rail Majra near Chandigarh, India is ISO 9001:2000 certified.The Company has its market presence not only in India but all across the world. The company has launched Max Devki Devi Heart and Vascular Institute in New Delhi, India which has opened opportunities in the fields of medical tourism and telemedicine. in the country. The offices of the company are spread in India, UK, US and Costa Rica.
Recently the company has entered into a joint venture with Bupa Group (Leading International Health and Care Company) with the name of Max Bupa in order to enter the health insurance market in India. The company has also restructured the joint venture agreement with New York Life to become the first insurer in India to declare Embedded Value Plans.The company's Healthcare division has planned to double the bed capacity to 1500 beds by the year 2010.
The company’s net profit shot up by 257 per cent to Rs. 13.61 crores for the Quarter Ended, June 2008 as against Rs. 3.81 crores during the Quarter Ended, June 2007. Net Sales of the company during this quarter surged by 89.6 % to Rs. 91.52 crores from Rs. 48.26 crores in the same time period last year.Total Income of the company witnessed a tremendous hike of 93% to Rs. 118.86 crores versus Rs. 61.61 crores in the corresponding time period last year while Total Expenses of the company also increased to Rs. 97.12 crores as against Rs. 52.15 crores during the same Quarter last year
I have reviewed the share price market of the company and the shares of the company have gradually increased for the last one month. The company has witnessed a hike of 39.45 points in the last one month. The Prices of the company as on 21st July, 2008 stood at Rs. 170.25. Since then the prices didn't dropped below this point. The company reached a high of 224.65 Rupees on 7th August, 2008. The prices saw a marginal decline after that to be closed at 209.70 points as on 21st August, 2008.
